FR2298320A1 - Compositions pharmaceutiques renfermant de l'hydrazide de n-benze - Google Patents

Compositions pharmaceutiques renfermant de l'hydrazide de n-benze

Info

Publication number
FR2298320A1
FR2298320A1 FR7502320A FR7502320A FR2298320A1 FR 2298320 A1 FR2298320 A1 FR 2298320A1 FR 7502320 A FR7502320 A FR 7502320A FR 7502320 A FR7502320 A FR 7502320A FR 2298320 A1 FR2298320 A1 FR 2298320A1
Authority
FR
France
Prior art keywords
hydrazide
benze
pharmaceutical compositions
compositions containing
pateint
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7502320A
Other languages
English (en)
French (fr)
Other versions
FR2298320B1 (https=
Inventor
Tsutomu Irikura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to FR7502320A priority Critical patent/FR2298320A1/fr
Publication of FR2298320A1 publication Critical patent/FR2298320A1/fr
Application granted granted Critical
Publication of FR2298320B1 publication Critical patent/FR2298320B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7502320A 1975-01-24 1975-01-24 Compositions pharmaceutiques renfermant de l'hydrazide de n-benze Granted FR2298320A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7502320A FR2298320A1 (fr) 1975-01-24 1975-01-24 Compositions pharmaceutiques renfermant de l'hydrazide de n-benze

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7502320A FR2298320A1 (fr) 1975-01-24 1975-01-24 Compositions pharmaceutiques renfermant de l'hydrazide de n-benze

Publications (2)

Publication Number Publication Date
FR2298320A1 true FR2298320A1 (fr) 1976-08-20
FR2298320B1 FR2298320B1 (https=) 1978-07-21

Family

ID=9150303

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7502320A Granted FR2298320A1 (fr) 1975-01-24 1975-01-24 Compositions pharmaceutiques renfermant de l'hydrazide de n-benze

Country Status (1)

Country Link
FR (1) FR2298320A1 (https=)

Also Published As

Publication number Publication date
FR2298320B1 (https=) 1978-07-21

Similar Documents

Publication Publication Date Title
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
BE845613A (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone
EP0151989A3 (en) Means for the treatment of cardiac diseases
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
GB984464A (en) Therapeutic compositions comprising bromelain
ZA763567B (en) Pharmaceutically active complexes and pharmaceutical compositions containing them
IE42950L (en) X-ray contrast preparations
FR2368958A1 (fr) Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique
SE7601535L (sv) Injicerbara antibiotiska kompositioner
DE3263832D1 (en) Gallium chloride, an anti-cancer drug
KR890004705A (ko) 항바이러스성 제제
IE45054L (en) Veterinary composition
MY100780A (en) Azumolene dosage form.
FR2298320A1 (fr) Compositions pharmaceutiques renfermant de l'hydrazide de n-benze
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
FR2374044A1 (fr) Agent anti-diabetique oral contenant une sulfonyluree et une kinine
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
BE889230A (fr) Nouveau medicaments veterinairespour hiniber le developpement des pro tozoaires et composition therapeutiques et formes pharmaceutiques contenant ces medicaments
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine
JPS5215813A (en) Preparation of stable medicine including homopyrimidazole derivative for aural administration

Legal Events

Date Code Title Description
ST Notification of lapse